[HTML][HTML] Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin, M Tang, A Kulasinghe… - Pharmaceuticals, 2020 - mdpi.com
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
[引用][C] Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin, M Tang… - …, 2020 - espace.library.uq.edu.au
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).
C O'Leary, H Gasper, KB Sahin, M Tang… - Pharmaceuticals …, 2020 - europepmc.org
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC).
C O'Leary, H Gasper, KB Sahin… - Pharmaceuticals …, 2020 - search.ebscohost.com
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
[HTML][HTML] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin, M Tang… - …, 2020 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
[PDF][PDF] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin, M Tang… - …, 2020 - pdfs.semanticscholar.org
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin, M Tang… - …, 2020 - eprints.qut.edu.au
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin, M Tang… - …, 2020 - search.proquest.com
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin… - Pharmaceuticals …, 2020 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
[PDF][PDF] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
C O'Leary, H Gasper, KB Sahin, M Tang… - …, 2020 - academia.edu
Epidermal growth factor receptor (EGFR) mutations are the most common oncogenic drivers
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …
in non-small-cell lung cancer (NSCLC). Significant developments have taken place which …